(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) announced Tuesday that its collaboration partner, Kissei Pharmaceutical Co., Ltd., has released positive topline results from its Phase 3 clinical trial ...
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) and The University of Texas MD Anderson Cancer Center announced a multi-year strategic development collaboration to expand the evaluation of REZLIDHIA in ...
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) announced the TAVALISSE (fostamatinib disodium hexahydrate) is available by prescription for the treatment of thrombocytopenia in adult patients with ...
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, clinical-stage drug development company Rigel Pharmaceuticals has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results